fbpx
FDR Station, PO Box 220
New York, NY 10150
1-800-ALZINFO (259-4636)
Phone: 1-212-915-1328
Email: info@alzinfo.org
CLOSE X
alzheimer's causes
Understanding Alzheimer’s DiseaseTop Ten Signs of Alzheimer’sClinical Stages of Alzheimer’sAlzheimer’s Disease Facts and StatisticsDementia vs Alzheimer’sYour Brain and Alzheimer’sSenile DementiaClinical Trials FAQsClinical Trials
alzheimer's care
CaregivingCaregiver’s CornerTherapeutic ActivitiesTips for the Caregivers from DoctorsDiet, Exercise & HealthCaregivers in TrainingHome ModificationContinuing CareBereavement and GriefLegal & Financial Planning
alzheimer's cure
Alzheimer’s ResearchAbout Our ResearchOur Research TeamProgress ReportsExplore Alzheimer’s Research
About Fisher Center FoundationAlzheimer’s NewsVideosResource LocatorMemory WallPreserving Your Memory® MagazineAsk The Experts
Copyright © 2024 The Fisher Center for Alzheimer's Research Foundation, a 501c3 not for profit,Tax ID # 13-3859563

LATEST ALZHEIMER'S RESEARCH NEWS YOU CAN USE

Expert reviewed Alzheimer’s and Dementia News

Category: Drugs and Treatment

Diabetes Treatments May Help Ward Off Alzheimer’s Disease
June 6, 2019
People with Type 2 diabetes should be treated promptly for their disease, which will not only help to manage their…
Learn More
Mushrooms Help Memory
Can Mushrooms Help Your Memory?
June 5, 2019
Eating mushrooms may be good for your brain. A study found that older men and women who ate mushrooms as…
Learn More
Buyer Beware: Dietary Supplement’s Won’t Cure Alzheimer’s Disease
February 28, 2019
The Food and Drug Administration is cracking down on makers of dietary supplements that claim to cure Alzheimer’s disease and…
Learn More
Experimental Drug, Fails to Benefit Alzheimer’s Patients
October 11, 2018
In a rigorous late-stage trial, an experimental drug called verubecestat failed to improve memory and thinking skills or slow the…
Learn More
New Drug Shows Promise for Alzheimer’s
September 18, 2018
A new drug showed promise in both reducing the plaques that build up in the brains of those with Alzheimer’s…
Learn More
Pain Relievers Present Special Hazards in People With Alzheimer’s Disease
September 5, 2018
People with Alzheimer’s disease and other forms of dementia were especially likely to suffer from harmful side effects from commonly…
Learn More
Care Management Program Is Reducing Need for Anti-anxiety Medication and Visits to the Hospital/Emergency Room
August 16, 2018
New York, NY, August 2018 – Last year researchers at the Zachary and Elizabeth M. Fisher Alzheimer Disease Education and…
Learn More
Music May Ease the Anxiety of Alzheimer’s
May 17, 2018
More good news on the music and Alzheimer’s front. Researchers report that music activates parts of the brain spared by…
Learn More
Experimental Alzheimer’s Drug, Intepirdine, Disappoints in Study
December 12, 2017
Late-stage trials of an experimental drug called intepirdine showed disappointing results in improving memory and thinking skills in people with…
Learn More
An Eye Scan for Alzheimer’s?
December 12, 2017
Researchers are getting closer to developing an eye scan to detect Alzheimer’s disease at its earliest stages, before symptoms become…
Learn More
Drug to treat Alzheimer’s is Ranked Highest
November 1, 2017
Aricept Ranks Highest Among Drugs to Treat Alzheimer’s A new analysis that looked at four drugs currently approved to treat…
Learn More
Patients Often Fail to Adhere to Alzheimer’s Drug Schedules
September 27, 2017
Many people with Alzheimer’s disease who start taking drugs for the condition stop taking them regularly or don’t take the…
Learn More
Could Treatments for Diabetes Help Treat Alzheimer’s?
November 16, 2016
A study shows new ways in which diabetes, a disorder of blood sugar control, may be linked to Alzheimer’s disease.…
Learn More
Pharmacists Can Aid in Alzheimer’s Care
June 6, 2016
Having a pharmacist as part of a health care team can improve care for anyone living with Alzheimer’s or other…
Learn More
Two-Drug Combo May Ease the Agitation of Alzheimer’s
May 4, 2016
Agitation is a common symptom of Alzheimer’s disease, and safe and effective treatments for the condition are lacking. Now, a…
Learn More
Are New, More Effective Alzheimer’s Drugs on the Horizon?
September 9, 2015
New data on two drugs in development, solanezumab and aducanumab, continue to raise hopes that new, more effective, drugs might…
Learn More
Nasal Spray Shows Promise as Alzheimer’s Treatment
May 1, 2015
A spray of insulin delivered deep into the nose improved memory and thinking skills in those with early Alzheimer’s disease.…
Learn More
Inflammation Holds Clues to Alzheimer’s Progression, and Possible Treatment
February 26, 2015
Researchers are discovering new ways in which inflammation and the immune system influence the progression of Alzheimer’s, offering new hope…
Learn More
Common Allergy and Sleep Drugs Tied to Higher Alzheimer’s Risk
February 13, 2015
Some drugs commonly used to treat hay fever, insomnia and depression have been linked to a higher risk of Alzheimer’s…
Learn More
Promising Drug, Gantenerumab, Fails to Prevent Alzheimer’s Onset
January 23, 2015
A promising investigational drug called gantenerumab failed to stem the slide into Alzheimer’s for people at high risk of developing…
Learn More
Blood Test Offers Hope for Early Diagnosis of Alzheimer’s
December 15, 2014
A novel blood test offers hope for diagnosing Alzheimer’s at its earliest stages, up to 10 years before symptoms like…
Learn More
Brain ‘Pacemaker’ Is Being Tested for Alzheimer’s Disease
December 2, 2014
Surgeons are testing a procedure called deep brain stimulation for people in the early stages of Alzheimer’s disease. The technique,…
Learn More
In Advanced Alzheimer’s, Too Many Medications
November 25, 2014
More than half of nursing home residents with advanced Alzheimer’s disease or other forms of dementia are taking at least…
Learn More
Rare Case Offers Hope for New Alzheimer’s Therapies
November 25, 2014
For about 20 years, the gene known as APOE has been recognized as a risk factor for Alzheimer’s disease. People…
Learn More
Previous
Next
WE CAN END ALZHEIMER'S

We support the pioneering research of the late Nobel Laureate Dr. Paul Greengard under the leadership of Dr. Nathaniel Heintz and his team as they continue pursuing the quest for a cure.

DONATE FOR THE CURE
We consistently receive top awards and ratings for our accountability:
Charity Navigator
GuideStar Gold Seal of Transparency
America's Best Charities
Combined Federal Campaign
Health and Medical Research Charities of America
Digital Health Awards

Connect with Us

Mailing Address:
The Fisher Center for Alzheimer's Research Foundation
FDR Station, PO Box 220
New York, NY 10150

1-800-ALZINFO (259-4636)
Phone: 1-212-915-1328
Email: info@alzinfo.org

Top Links

Understanding Alzheimer’s DiseaseAlzheimer's DiagnosisDementia vs. Alzheimer'sTop Ten Signs of Alzheimer'sClinical Stages of Alzheimer’s

About Fisher

About UsFinancialsTerms of ServicePrivacy Policy501 C 3 Letter

Information Program

Alzheimer’s NewsPreserving Your Memory® MagazineResource LocatorCaregiver’s CornerVideos
Copyright © 2024 The Fisher Center for Alzheimer's Research Foundation, a 501c3 not for profit,Tax ID # 13-3859563